COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
619 Million Affected by Low Back Pain Globally in 2020
TUESDAY, May 30, 2023 (HealthDay News) -- Overall, 619 million people were...
Managing Stress
We all know what stress feels like. The jittery stomach and sweaty palms when...
Stable Neurodevelopment Seen for Most Children With Familial High Risk for Schizophrenia
FRIDAY, Nov. 18, 2022 (HealthDay News) -- Most children at familial high risk...